Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q3 2023 Earnings Presentation
10 slides from Phibro Animal Health's earnings presentation, May 4, 2023
Slide 1: Phibro Animal Health Corporation Webcast and Conference Call
Phibro Animal Health Corporation Webcast and Conference Call May 4, 2023 Financial Results U.S. toll-free +1.888.330.2022 Fiscal Year 2023 International toll +1.365.977.0051 Third Quarter Ended March 31, 2023 Conference ID: [3927884] 1 May 4, 2023 Webcast & Conference Call
Slide 2: Important Information
Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to future debt and leverage levels. All statements other than statements of historical or current
Slide 3: Key Themes
Key Themes Third Quarter Continued opportunities Strong fiscal Margins should improve We are reiterating for growth in Animal year-to-date over time as input costs guidance for the year Health, including net sales growth return to historical levels ending June 30, 2023 companion animals Fiscal year-
Slide 4: Financial Performance - Consolidated
Financial Performance - Consolidated Third Quarter, Year-on-Year comparison $ in millions, except per share data Net Sales – increased $6.1 million, or 3%, driven by improvement in our largest segment, Animal Health, partially offset by declines in Mineral Nutrition and Performance Products Net
Slide 5: Financial Performance – Animal Health
Financial Performance – Animal Health Third Quarter, Year-on-Year comparison $ in millions Net Sales – increased $15.8 million, or 11% YOY MFAs and other - Increased $8.9 million, or 11%, due to increased Q3 %∆ demand for MFAs in the US and Latin America & Canada regions and increased demand for
Slide 6: Financial Performance – Other Segments
Financial Performance – Other Segments Third Quarter, Year-on-Year comparison $ in millions YOY Mineral Nutrition Q3 %∆ - Net sales decreased $6.1 million, or 9%, primarily driven by a Mineral Nutrition decrease in demand for trace minerals, partially offset by higher Net Sales $ 62.9 (9%) selling
Slide 7: Key Capitalization Metrics
Key Capitalization Metrics Third Quarter Highlights $m QE QE QE QE 6.30.22 9.30.22 12.31.22 03.31.23 TTM -$43 million of trailing 12-month free cash flow; Free Cash Flow operating cash flow of -$5 million less capital Operating Cash Flow $ 2 $ (11) $ (2) $ 6 $ (5) expenditures of $38 million1 Less:
Slide 8: Financial Guidance
Financial Guidance Fiscal Year 2023 $ in millions, except earnings per share (EPS) data We are reiterating guidance for Net Sales, Net Income, Diluted EPS, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted Earnings Per Share and our Adjusted Effective Tax Rate. 8 May 4, 2023 Webcast & Confere
Slide 9: Environmental, Social & Governance Report
Environmental, Social & Governance Report We will be publishing our second annual Environmental, Social & Governance Report next week. 9 May 4, 2023 Webcast & Conference Call
Slide 10: © 2023 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy
© 2023 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that